Clinical and imaging experience with COVID-19 in nonvaccinated children with cancer.
- Resource Type
- Article
- Authors
- Behr, Gerald G.; Raphael, Joseph P.; Price, Anita P.; Pandit-Taskar, Neeta
- Source
- Clinical Imaging. Oct2022, Vol. 90, p1-4. 4p.
- Subject
- *DIAGNOSTIC imaging
*CHILDHOOD cancer
*COVID-19
*HEMATOLOGIC malignancies
*TUMORS in children
- Language
- ISSN
- 0899-7071
Children with COVID-19 fare much better than adults but less is known about children with both COVID-19 and a cancer diagnosis in terms of clinical outcome and imaging. We describe our experience with a cohort of children with COVID-19 and cancer who have undergone medical imaging. We reviewed imaging and recorded clinical data and separated this group into two subgroups - hematologic and solid malignancies. Our observational data show that 1)children with hematologic malignancies may be at higher risk for complications, including death than, those with solid tumors, 2) that pulmonary imaging in the former group more often shows abnormalities and 3) that presence of pulmonary imaging abnormalities may portend an unfavorable outcome. • Children with hematologic malignancies are at greater risk of morbidity and mortality from COVID-19 than are children with solid tumors. • Children with hematologic malignancies and COVID-19 appear to be more likely to exhibit abnormalities on chest imaging than are children with solid tumors. • Children with hematologic malignancies and COVID-19 who have evidence of pneumonia on chest imaging studies may have worse outcomes than children with solid tumors. [ABSTRACT FROM AUTHOR]